Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-08T22:41:28.763Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuropsychiatric symptoms and their neural correlates in individuals with mild cognitive impairment

Published online by Cambridge University Press:  30 January 2023

Natascia De Lucia Open the ORCID record for Natascia De Lucia [Opens in a new window] ,
Giovanni Carbone ,
Benedetta Muzii ,
Nicola Ferrara ,
Giuseppe Rengo ,
Nelson Mauro Maldonato ,
Grazia Daniela Femminella Open the ORCID record for Grazia Daniela Femminella [Opens in a new window]  and
Alzheimer’s Disease Neuroimaging Initiative
Natascia De Lucia*
Affiliation:
Department of Neurosciences, Reproductive and Odontostomatological Sciences, “Federico II” University, Naples, Italy
Giovanni Carbone
Affiliation:
Department of Translational Medical Sciences, “Federico II” University, Naples, Italy
Benedetta Muzii
Affiliation:
Department of Humanistic Studies, “Federico II” University, Naples, Italy
Nicola Ferrara
Affiliation:
Department of Translational Medical Sciences, “Federico II” University, Naples, Italy
Giuseppe Rengo
Affiliation:
Department of Translational Medical Sciences, “Federico II” University, Naples, Italy Instituti Clinici Scientifici Maugeri IRCCS - Scientific Institute of Telese Terme (BN), Telese BN, Italy
Nelson Mauro Maldonato
Affiliation:
Department of Neurosciences, Reproductive and Odontostomatological Sciences, “Federico II” University, Naples, Italy
Grazia Daniela Femminella*
Affiliation:
Department of Translational Medical Sciences, “Federico II” University, Naples, Italy Department of Brain Sciences, Imperial College London, London, UK
*
Correspondence should be addressed to: Natascia De Lucia and Grazia Daniela Femminella, via S. Pansini 5, 80131, Naples, Italy. Phone: +39 0817682480; Fax: +39 0817682480. Email: [email protected]; [email protected].
Correspondence should be addressed to: Natascia De Lucia and Grazia Daniela Femminella, via S. Pansini 5, 80131, Naples, Italy. Phone: +39 0817682480; Fax: +39 0817682480. Email: [email protected]; [email protected].
Get access

Abstract

Objectives:

Neuropsychiatric symptoms are common in subjects with MCI and associated with higher risk of progression to AD. The cognitive and neuroanatomical correlates of neuropsychiatric symptoms in MCI have not been fully elucidated. In this study, we sought to evaluate the association between neuropsychiatric symptoms, cognitive function, regional tau deposition, and brain volumes in MCI subjects.

Methods:

A total of 233 MCI and 305 healthy comparisons were selected from the ADNI-3 cohort. All the subjects underwent a comprehensive neuropsychological assessment, volumetric MR brain scan, and Flortaucipir PET for in vivo assessment of regional tau deposition. Prevalence of neuropsychiatric symptoms was evaluated by means of the NPI questionnaire. Multivariate analyses of variance were used to detect differences in cognitive and imaging markers in MCI subjects with and without neuropsychiatric symptoms.

Results:

61.4% MCI subjects showed at least one neuropsychiatric symptom, with the most prevalent ones being depression (26.1%), irritability (23.6%), and sleep disturbances (23.6%). There was a significant effect of neuropsychiatric symptoms on cognitive tests of frontal and executive functions. MCI subjects with neuropsychiatric symptoms showed reduced brain volumes in the orbitofrontal and posterior cingulate cortices, while no effects were detected on regional tau deposition. Posterior cingulate cortex volume was the only predictor of global neuropsychiatric burden in this MCI population.

Conclusions:

Neuropsychiatric symptoms occur early in the AD trajectory and are mainly related to defects of control executive abilities and to the reduction of gray matter volume in the orbitofrontal and posterior cingulate cortices. A better understanding of the cognitive and neuroanatomical mechanisms of neuropsychiatric symptoms in MCI could help develop more targeted and efficacious treatment alternatives.

Keywords

mild cognitive impairmentneuropsychiatric inventoryfrontal functionsADNI-3
Type
Original Research Article
Information
International Psychogeriatrics , Volume 35 , Special Issue 11: Issue Theme: Neuropsychiatric Symptoms of Mild and Major Neurocognitive Disorders , November 2023 , pp. 623 - 632
Copyright
© International Psychogeriatric Association 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

An affiliation has been added for Giuseppe Rengo. An addendum detailing this change has also been published (doi: 10.1017/S1041610223000376).

Data used IN preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate IN analysis OR writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

References

Alves, G. S., et al. (2017). Neuroimaging findings related to behavioral disturbances in Alzheimer’s disease: a systematic review. Current Alzheimer Research, 14, 61–75. https://doi.org/10.2174/1567205013666160603010203.CrossRefGoogle ScholarPubMed
American Psychiatric Association (APA) (1994). Diagnostic and statistical manual of mental disorders (DSM-IV). Washington: American Psychiatric Association.Google Scholar
Bayard, S., Jacus, J-P., Raffard, S., Gely-Nargeot, M-C. (2014). Apathy and emotion-based decision making in amnesic mild cognitive impairment and Alzheimer’s disease. Behavioral Neurology, 2014, 231469–7, 2014, https://doi.org/10.1155/2014/231469,Google ScholarPubMed
Beaudreau, S. A. and O’Hara, R. (2008). Late-life anxiety and cognitive impairment: a review. American Journal of Geriatric Psychiatry, 16, 790–803.10.1097/JGP.0b013e31817945c3CrossRefGoogle ScholarPubMed
Bloniecki, V., Aarsland, D., Cummings, J., Blennow, K. and Freund-Levi, Y. (2014). Agitation in dementia: relation to core cerebrospinal fluid biomarker levels. Dementia and Geriatric Cognitive Disorders Extra, 4, 335–343, https://doi.org/10.1159/000363500,CrossRefGoogle ScholarPubMed
Boublay, N., Schott, A. M. and Krolak-Salmon, P. (2016). Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer’s disease: a review of 20 years of research. European Journal of Neurology, 23, 1500–1509. https://doi.org/10.1111/ene.13076.CrossRefGoogle ScholarPubMed
Brodaty, H. et al. (2012). Neuropsychiatric symptoms in older people with and without cognitive impairment. Journal of Alzheimers Disease, 31, 411–420.10.3233/JAD-2012-120169CrossRefGoogle ScholarPubMed
Cahn, D. A. et al. (1996). Screening for dementia of the Alzheimer type in the community: the utility of the Clock Drawing Test. Archives of Clinical Neuropsychology, 11, 529–539. https://doi.org/10.1016/0887-6177(95)00041-0.CrossRefGoogle ScholarPubMed
Cassidy, C. M. et al. (2022). Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease. Neuropsychopharmacology, 47, 1128–1136.10.1038/s41386-022-01293-6CrossRefGoogle ScholarPubMed
Cummings, J. L. (1997). The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology, 48, 10–16.10.1212/WNL.48.5_Suppl_6.10SCrossRefGoogle ScholarPubMed
Delrieu, J. et al. (2015). Apathy as a feature of prodromal Alzheimer’s disease: an FDG-PET ADNI study. International Journal of Geriatric Psychiatry, 30, 470–477. https://doi.org/10.1002/gps.4161.CrossRefGoogle ScholarPubMed
De Lucia, N., Grossi, D., Mauro, A. and Trojano, L. (2015). Closing-in in Parkinson’s disease individuals with dementia: an experimental study. Journal of Clinical and Experimental Neuropsychology, 37, 946–955.10.1080/13803395.2015.1071339CrossRefGoogle ScholarPubMed
De Rosa, A. et al. (2018). Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson’s disease. Parkinsonism and Related Disorders, 47, 80–83.10.1016/j.parkreldis.2017.12.008CrossRefGoogle ScholarPubMed
Femminella, G. D., Harold, D., Scott, J., Williams, J. and Edison, P. (2021). The differential influence of immune, endocytotic, and lipid metabolism genes on amyloid deposition and neurodegeneration in subjects at risk of Alzheimer’s disease. Journal of Alzheimers Disease, 79, 127–139.10.3233/JAD-200578CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini-mental state. Journal of Psychiatric Research, 12, 189–198.10.1016/0022-3956(75)90026-6CrossRefGoogle ScholarPubMed
Fuller, J. T., Choudhury, T. K., Lowe, D. A. and Balsis, S. (2020). Hallucinations and delusions signal Alzheimer’s associated cognitive dysfunction more strongly compared to other neuropsychiatric symptoms. Journal of Gerontology. Serie B, Psychological Sciences and Social Sciences, 75, 1894–1904. https://doi.org/10.1093/geronb/gbz032.CrossRefGoogle ScholarPubMed
García-Alberca, J. M., Florido, M., Cáceres, M., Sànchez-Toro, A., Lara, J. P. and Garcìa-Casares, N. (2008). Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer’s disease. Psychogeriatrics, 19, 46–54.10.1111/psyg.12363CrossRefGoogle Scholar
Geda, Y. E., Roberts, R. O. and Knopman, D. S. (2008). Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Archives of General Psychiatry, 65, 1193–1198.10.1001/archpsyc.65.10.1193CrossRefGoogle ScholarPubMed
Geda, Y. E. et al. (2014). Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. American Journal of Psychiatry, 171, 572–581.10.1176/appi.ajp.2014.13060821CrossRefGoogle ScholarPubMed
Gollan, T. H., Weissberger, G. H., Runnqvist, E., Montoya, R. I. and Cera, C. M. (2012). AffiliatioSelf-ratings of spoken language dominance: a multi-lingual naming test (MlNT) and preliminary norms for young and aging Spanish-English bilinguals. Bilingualism (Cambridge, England), 15, 594–615. https://doi.org/10.1017/S1366728911000332.Google Scholar
Grossi, D., De Lucia, N. and Trojano, L. (2015). Closing-in is related to apathy in Alzheimer’s disease patients. Journal of Alzheimer’s Disease, 43, 849–855.10.3233/JAD-141257CrossRefGoogle ScholarPubMed
Jang, J. Y. et al. (2020). Affective neuropsychiatric symptoms as early signs of dementia risk in older adults. Journal of Alzheimer’s Disease, 77, 1195–1207.10.3233/JAD-200190CrossRefGoogle ScholarPubMed
Kim, H. et al. (2022). The role of amyloid, tau, and APOE genotype on the relationship between informant-reported sleep disturbance and Alzheimer’s disease risks. Journal of Alzheimer’s Disease, 87, 1567–1580. https://doi.org/10.3233/JAD-215417.CrossRefGoogle ScholarPubMed
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J. and DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. Journal of the American Medical Association, 288, 1475–1483.10.1001/jama.288.12.1475CrossRefGoogle ScholarPubMed
Lussier, F. Z. et al. (2020). Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dementia, 16, 192–199.10.1002/alz.12007CrossRefGoogle ScholarPubMed
Mah, L., Binns, M. A., Steffens, D. C. and Alzheimer’s Disease Neuroimaging Initiative (2015). Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. American Journal of Geriatric Psychiatry, 23, 466–476, https://doi.org/10.1016/j.jagp.2014.10.005,CrossRefGoogle ScholarPubMed
Mallo, S. C. et al. (2018). Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with mild cognitive impairment. Journal of Alzheimers Disease, 66, 83–95. https://doi.org/10.3233/JAD-180131.CrossRefGoogle ScholarPubMed
Maresova, P., Hruska, J., Klimova, B., Barakovic, S. and Krejcar, O. (2020). Activities of daily living and associated costs in the most widespread neurodegenerative diseases: a systematic review. Clinical Interventions in Aging, 15, 1841–1862.10.2147/CIA.S264688CrossRefGoogle ScholarPubMed
Martin, E. and Velayudhan, L. (2020). Neuropsychiatric symptoms in mild cognitive impairment: a literature review. Dementia and Geriatric Cognition Disorders, 49, 146–155. https://doi.org/10.1159/000507078.CrossRefGoogle ScholarPubMed
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.10.1212/WNL.43.11.2412-aCrossRefGoogle ScholarPubMed
Ng, K. P. et al. (2017). Alzheimer’s Disease Neuroimaging Initiative. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology, 9, 1814–1821.10.1212/WNL.0000000000003916CrossRefGoogle Scholar
Palmer, K. et al. (2010). Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy. Journal of Alzheimers Disease, 20, 175–183. https://doi.org/10.3233/JAD-2010-1352.CrossRefGoogle ScholarPubMed
Premnath, P. Y., Gonzalez, C., Properzi, M. J., Rosenberg, P. B., Marshall, G. A. and Gatchel, J. R. (2021). Longitudinal associations of regional cortical tau and apathy in mild cognitive impairment and Alzheimer’s disease dementia: findings from the Alzheimer’s Disease Neuroimaging Initiative. Alzheimer’s Dementia, 17, e056204.10.1002/alz.056204CrossRefGoogle Scholar
Ramusino, M. C. et al. (2021). Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience. Frontiers in Aging Neuroscience, 13, 595758. https://doi.org/10.3389/fnagi.2021.595758.CrossRefGoogle Scholar
Ramakers, I. H. G. B., Verhey, F. R. J. and Scheltens, P. (2013). Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychological Medicine, 43, 911–920.10.1017/S0033291712001870CrossRefGoogle ScholarPubMed
Reitan, R. M. (1958). Validity of the trail-making test as an indicator of organic brain damage. Perception and Motor Skills, 8, 271–276.10.2466/pms.1958.8.3.271CrossRefGoogle Scholar
Rey, A. (1964). L’examen Clinique en psychologie. Paris: Presses Universitaires de Franc.Google Scholar
Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984). A new rating scale for Alzheimer’s disease. American Journal of Psychiatry, 141, 1356–1364.Google ScholarPubMed
Showraki, A. et al. (2019). Cerebrospinal fluid correlates of neuropsychiatric symptoms in patients with Alzheimer’s Disease/Mild Cognitive Impairment: a systematic review. Journal of Alzheimers Disease, 71, 477–501.10.3233/JAD-190365CrossRefGoogle ScholarPubMed
Siafarikas, N. et al. (2021). Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer’s disease with dementia. International Psychogeriatrics, 33, 1217–1228. https://doi.org/10.1017/S1041610221000934.CrossRefGoogle ScholarPubMed
Sun, Y. et al. (2021). Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology. Translational Psychiatry, 11, 577. https://doi.org/10.1038/s41398-021-01675-2.CrossRefGoogle ScholarPubMed
Tampi, R. and Jeste, D.V. (2022). Dementia is more than memory loss: neuropsychiatric symptoms of dementia and their non-pharmacological and pharmacological management. American Journal of Psychiatry, 179, 528–543, https://doi.org/10.1176/appi.ajp.20220502,CrossRefGoogle Scholar
Victoroff, J., Lin, F. V., Coburn, K. L., Shillcutt, S. D., Voon, V. and Ducharme, S. (2018). Noncognitive behavioral changes associated with Alzheimer’s disease: implications of neuroimaging findings. Journal of Neuropsychiatry and Clinical Neurosciences, 30, 14–21. https://doi.org/10.1176/appi.neuropsych.16080155.CrossRefGoogle ScholarPubMed
Wechsler, D. A. (1987). Manual for the Wechsler Memory Scale-revised. New York: Psychological Corporation.Google Scholar
Yasuno, F., Matsuoka, K., Miyasaka, T., Takahashi, M., Kitamura, S., Yoshikawa, H., Hattori, H., Kichikawa, K. and Kishimoto, T. (2019). Decreased perfusion of the posterior cingulate gyri shown by a cingulate island score is a possible marker of vulnerability to behavioural and psychological symptoms of Alzheimer’s disease: a pilot study. Psychogeriatrics, 19, 165–170.10.1111/psyg.12379CrossRefGoogle ScholarPubMed
Supplementary material: File

De Lucia et al. supplementary material

De Lucia et al. supplementary material 1

Download De Lucia et al. supplementary material(File)
File 88.5 KB
Supplementary material: Image

De Lucia et al. supplementary material

De Lucia et al. supplementary material2

Download De Lucia et al. supplementary material(Image)
Image 109.6 KB